You are here

Show:
Printer-friendly versionPrinter-friendly version
  • Zarin D. Factual Errors about ClinicalTrials.gov and other federal mandates in special report by Shuster [Letter]. Clin Transl Sci. 2012 Apr;5(2):217; author reply 217. doi: 10.1111/j.1752-8062.2012.00410.x.
  • Zarin D, Tse T. The effect of funding source on outcome reporting among drug trials [Letter]. Ann Intern Med. 2011 Jan 18;154(2):137-8; author reply 138. doi: 10.7326/0003-4819-154-2-201101180-00020.
  • Zarin DA, Tse T. Unambiguous identification of obesity trials [Letter]. N Engl J Med. 2013 Feb 7;368(6):580-1. doi: 10.1056/NEJMc1215018.
  • Zarin DA, Tse T. Tracking health services research studies [Letter]. JAMA. 2008 Nov 19;300(19):2252; author reply 2252. doi: 10.1001/jama.2008.612.
  • Zeng K, Bodenreider O, Kilbourne J, Nelson SJ. Standards, Security and Usability: Experience with MyMedicationList [Abstract]. Proc. AMIA Spring Congress 2008
  • Zeng K, Bodenreider O. Experience in Integrating Large RDF-based Biomedical Knowledge Resources with Oracle [Abstract]. Proc 8th International Oracle Life Sciences User Group Meeting 2007:(electronic proceedings: http://www.olsug.org/wiki/images/d/d1/Kelly_Zheng.pdf)

Pages